Metabolism of Methylisoeugenol in Liver Microsomes of Human, Rat, and Bovine Origin
作者:Alexander T. Cartus、Karl-Heinz Merz、Dieter Schrenk
DOI:10.1124/dmd.111.038851
日期:2011.9
Methylisoeugenol (1,2-dimethoxy-4-propenylbenzene, 1) is a minor constituent of essential oils, naturally occurring as a mixture of cis/trans isomers. 1 is a U.S. Food and Drug Administration-approved food additive and has been given “Generally Recognized as Safe” status. Previously, metabolism of 1 has been studied in the rat, revealing mainly nontoxic cinnamoyl derivatives as major metabolites. However, data concerning the possible formation of reactive intermediary metabolites are not available to date. In this study, the oxidative metabolism of 1 was studied using liver microsomes of rat [not induced, rat liver microsomes (RLM); Aroclor1254 induced RLM (ARLM)], bovine, and human (pooled from 150 donors) origin. Incubations of these microsomes with 1 provided phase I metabolites that were separated by high-performance liquid chromatography (HPLC) and identified by NMR and UV-visible spectroscopy and/or liquid chromatography-mass spectrometry. Identity was confirmed by comparison with 1H NMR spectra of synthesized reference compounds. Formation of metabolites was quantified by HPLC/UV using dihydromethyleugenol (10) synthesized as the internal standard. From incubations of ARLM with 1, seven metabolites could be detected, with 3′-hydroxymethylisoeugenol (2), isoeugenol and isochavibetol (3 + 4), and 6-hydroxymethylisoeugenol (5) being the main metabolites. Secondary metabolites derived from 1 were identified as the α,β-unsaturated aldehyde 3′-oxomethylisoeugenol (6) and 1′,2′-dihydroxy-dihydromethylisoeugenol (7). We were surprised to find that formation of allylic 6-hydroxymethyleugenol (8) was observed starting at approximately 30 min after the beginning of incubations with ARLM. HLM did not form ring-hydroxylated metabolites but were most active in the formation of 6 and 7. ARLM incubations displayed the highest turnover rate and broadest metabolic pattern, presumably resulting from an increased expression of cytochrome P450 enzymes. In conclusion, we present a virtually complete pattern of nonconjugated microsomal metabolites of 1 comprising reactive metabolites and suggest the formation of reactive intermediates that need more investigation with respect to their possible adverse properties.
美克尔异香豆烯(1,2-二甲氧基-4-丙烯基苯,1)是精油中的次要成分,自然以顺式/反式异构体的混合物存在。1是美国食品药品管理局批准的食品添加剂,并已被认定为“普遍认为安全”。此前,已经在大鼠中研究了1的代谢,主要发现无毒的肉桂酸衍生物作为主要代谢物。然而,目前尚无关于可能形成反应性中间代谢物的数据。在本研究中,我们使用大鼠(未诱导的大鼠肝微粒体;Aroclor1254诱导的大鼠肝微粒体(ARLM))、牛和人类(来自150名供体的 pooled)肝微粒体研究了1的氧化代谢。将这些微粒体与1共同孵育后,获得了第一相代谢物,这些代谢物通过高效液相色谱(HPLC)分离,并通过核磁共振(NMR)和紫外-可见光谱分析和/或液相色谱-质谱法(LC-MS)进行鉴定。通过与合成的对照化合物的1H NMR光谱进行比较来确认其身份。代谢物的形成通过使用合成的内标二氢美克尔异香豆烯(10)进行HPLC/UV定量。从ARLM与1的孵育中,可以检测到七种代谢物,主要代谢物包括3′-羟甲基美克尔异香豆烯(2)、美克尔异香豆烯及异香豆醇(3 + 4),以及6-羟甲基美克尔异香豆烯(5)。从1衍生的次级代谢物被确定为α,β-不饱和醛3′-氧甲基美克尔异香豆烯(6)和1′,2′-二羟基-二氢美克尔异香豆烯(7)。我们惊讶地发现,观察到烯丙基6-羟甲基美克尔异香豆烯(8)的形成,起始于与ARLM孵育约30分钟后。人类肝微粒体(HLM)未形成环羟基化代谢物,但在6和7的形成方面最为活跃。ARLM的孵育显示出最高的周转率和最广泛的代谢模式,这可能是由于细胞色素P450酶的表达增加。总之,我们呈现了1的几乎完整的非结合微粒体代谢物谱,包含反应性代谢物,并建议形成需要更多研究以了解其潜在不良性质的反应性中间体。